DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma

Image 3-DANYELZA (naxitamab-gqgk)
DANYELZA is available in 4mg/ml strength in a single-dose vial. Credit: Y-mAbs Therapeutics, Inc.